All SEC Filings :: Syros Pharmaceuticals, Inc. (SYRS)

Filing Type:

Year:

Date	Form	Description	Pages
12/01/22	S-3/A	Registration statement for specified transactions by certain issuers Documents EX-23.1 EX-23.2	32
12/01/22	8-K/A	Current report filing Documents EX-23.1 EX-99.3	17
11/30/22	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	3
11/14/22	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-3.1 EX-10.8 EX-10.10 EX-10.11 EX-10.12 EX-10.13 EX-31.1 EX-31.2 EX-32.1 EX-32.2	119
11/10/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	3
10/28/22	UPLOAD	SEC-generated letter Documents TEXT-EXTRACT	2
10/14/22	S-3	Registration statement for specified transactions by certain issuers Documents EX-5.1 EX-23.1 EX-FILING FEES	34
10/13/22	4	Statement of changes in beneficial ownership of securities	1
10/13/22	3	Initial statement of beneficial ownership of securities Documents EX-24	2
10/11/22	4/A	Statement of changes in beneficial ownership of securities Documents EX-24	2